Skip to content

Clinical study on early diagnosis and progression monitoring of peritoneal fibrosis using FAPI-PET imaging

Clinical study on early diagnosis and progression monitoring of peritoneal fibrosis using FAPI-PET imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300079318
Enrollment
Unknown
Registered
2023-12-30
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peritoneal fibrosis

Interventions

Index test:peritoneal equilibration test FAPI-PET/CT

Sponsors

the First Affiliated Hospital of the People's Liberation Army Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Selection criteria: 1) 18-80 years old; 2) Newly diagnosed PD patients who need to undergo or are currently undergoing PD; 3) The patient agrees to undergo FAPI-PET imaging on the basis of a balanced trial; 4) Sign a written informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1) Patients with malignant conditions such as abdominal tumors; 2) Minors, pregnant women, and lactating women; 3) Patients with peritonitis; 4) Patients who require abdominal surgery during PD; 5) Individuals with a history of allergy to contrast agents or other medications.

Design outcomes

Primary

MeasureTime frame
SUVmax;Creatinine D/P ratio;

Secondary

MeasureTime frame
Scr;BUN;

Countries

China

Contacts

Public ContactFei Kang

the First Affiliated Hospital of the People's Liberation Army Air Force Military Medical University

fmmukf@qq.com+86 139 9136 5070

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026